A clinical-stage company developing a gene therapy combination product for hearing restoration was preparing for the next phase of product development and needed to establish a robust Quality Management System (QMS) for its medical device operations.
While the medical device organization was relatively small, it operated within the governance of a large global pharmaceutical parent company. The client needed a QMS that not only met medical device regulatory requirements but also fit within the broader corporate quality framework.
To support future commercialization, the quality system also needed to align with regulatory requirements across the United States, European Union, and MDSAP participating countries, while incorporating select country-specific requirements.
The Challenge
Developing a quality system for a small organization is one challenge. Developing one that also aligns with the expectations of a global parent organization is another.
AlvaMed partnered with the client to:
- Develop a complete, implementation-ready Quality Management System for its medical device operations.
- Customize the quality system to reflect the client’s organizational structure and operating model.
- Ensure alignment with FDA QMSR, EU MDR, and MDSAP country requirements.
- Incorporate additional applicable country-specific regulatory requirements to support global expansion.
- Define roles and responsibilities that would enable efficient implementation.
- Position the organization for future audits and ongoing quality system maturity.
Although regulatory compliance formed the foundation of the project, integrating the parent organization’s quality expectations required careful interpretation and customization.
AlvaMed’s Approach
Rather than starting from a blank page, AlvaMed leveraged its proven QMS in a Box framework to accelerate development while ensuring compliance with standard medical device regulations.
The engagement began by establishing a document Style Guide, creating a consistent structure across the quality system before individual procedures were drafted.
Tailoring the Quality System
Working closely with the client’s team, AlvaMed customized each SOP and form to reflect the organization’s operating model.
Because the medical device group consisted of a small number of employees performing multiple functions, clearly defining responsibilities became a critical component of the project. AlvaMed developed responsibility matrices that clarified process ownership and provided the foundation for employee training and implementation.
Supporting Global Regulatory Compliance
To support the client’s global regulatory strategy, AlvaMed developed procedures aligned with:
- FDA Quality Management System Regulation (QMSR)
- European Union Medical Device Regulation (EU MDR)
- MDSAP participating country regulations
Where appropriate, additional country-specific regulatory requirements – including select requirements for markets such as Saudi Arabia and Taiwan – were incorporated into applicable procedures.
Leveraging AI-Assisted Regulatory Analysis
To efficiently identify international regulatory requirements, AlvaMed utilized a proprietary AI-assisted regulatory analysis to compare global regulations and highlight country-specific requirements.
Rather than replacing regulatory expertise, the technology accelerated the identification of relevant requirements, allowing AlvaMed’s consultants to validate the findings and incorporate applicable requirements into the quality system.
This approach reduced manual research while maintaining expert oversight throughout the development process.
Results
AlvaMed delivered a fully customized, implementation-ready Quality Management System that included:
- A comprehensive suite of SOPs and supporting forms
- Procedures aligned with FDA QMSR, EU MDR, and MDSAP country requirements
- Country-specific regulatory additions where appropriate
- Clearly defined organizational roles and responsibilities
- Responsibility matrices supporting employee training and implementation
The completed QMS enabled the client to begin implementation immediately and prepare for corporate quality oversight.
Following delivery, the engagement expanded to include internal auditing, management review support, and ongoing quality system improvements -demonstrating the client’s confidence in AlvaMed as a long-term quality partner.
Key Takeaways
Building an effective Quality Management System requires more than meeting regulatory requirements. Organizations operating within larger corporate structures must also ensure that their quality systems align with internal governance while remaining practical for day-to-day operations.
By combining proven QMS templates, global regulatory expertise, AI-assisted regulatory analysis, and collaborative customization, AlvaMed helped the client establish a scalable quality system that supports clinical development today while providing a strong foundation for future commercialization.
